CSIMarket
 
Medtronic Plc  (MDT)
Other Ticker:  
 
 
Price: $79.7500 $-0.20 -0.250%
Day's High: $80.345 Week Perf: -3.02 %
Day's Low: $ 79.17 30 Day Perf: -7.18 %
Volume (M): 7,012 52 Wk High: $ 91.00
Volume (M$): $ 559,207 52 Wk Avg: $81.99
Open: $79.92 52 Wk Low: $68.84



 Market Capitalization (Millions $) 106,203
 Shares Outstanding (Millions) 1,332
 Employees 95,000
 Revenues (TTM) (Millions $) 32,319
 Net Income (TTM) (Millions $) 4,234
 Cash Flow (TTM) (Millions $) -2,899
 Capital Exp. (TTM) (Millions $) 1,539

Medtronic Plc
Medtronic is a world leading medical technology company, providing lifelong solutions for people with chronic disease. We are committed to offering market-leading therapies worldwide to restore patients to fuller, healthier lives. With beginnings in the treatment of heart disease, we have expanded well beyond our historical core business and today provide a wide range of products and therapies that help solve many challenging, life-limiting medical conditions. We hold market-leading positions in almost all of the major markets in which we compete.


   Company Address: 20 On Hatch, Lower Hatch Street Dublin 2 0
   Company Phone Number: 438-1700   Stock Exchange / Ticker: NYSE MDT
   


Customers Net Income fell by MDT's Customers Net Profit Margin fell to

-1.34 %

2.96 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BDX   -0.11%    
BSX   -1.42%    
EW        0.85% 
ISRG        1.61% 
PDCO        11.02% 
SYK        0.65% 
• View Complete Report
   



Stock Offering

Medtronic plc Bolsters Financial Flexibility with $3.0 Billion Pricing of Senior Notes Offering

Published Wed, May 29 2024 9:10 PM UTC

Medtronic plc Prices $3.0 Billion Senior Notes Offering, Boosting Financial Flexibility
DUBLIN, May 29, 2024 - Medtronic plc (NYSE: MDT) announced today that its subsidiary, Medtronic, Inc., has priced an offering of $3.0 billion in senior notes due in 2029. The offering consists of 3.650% senior notes, which will be used for general corporate purposes, including potenti...

Medtronic Plc

Medtronic Plc Reports Strong Growth in Earnings and Revenue for Q3 2024

Medtronic Plc, a global leader in healthcare technology, recently reported its third-quarter results for 2024. The company experienced a revenue growth of 4.685% to $8.09 billion compared to $7.73 billion in the same reporting season the previous year. This represents a solid performance, although it falls short of the 8.27% top-line improvement reported by its contemporaries in the Medical Equipment & Supplies sector.
In terms of earnings per share (EPS), Medtronic Plc saw an increase of 7.61% to $0.99 from $0.92 in the prior year reporting season. The company's bottom-line also showed improvement, with net earnings of $1,337.000 million in the third quarter of 2024, an 8.79% increase from $1,229.000 million reported in the same period a year ago.

Products & Services

Medtronic Unveils Cutting-Edge Percept RC Neurostimulator with BrainSense Technology, Revolutionizing Deep Brain Stimulation

Published Mon, Jan 8 2024 5:38 PM UTC

FDA Approves Medtronic's Advanced Percept RC Neurostimulator with Exclusive BrainSense Technology: Revolutionizing Deep Brain StimulationIn a breakthrough development, the FDA has granted approval to Medtronic for its latest innovation - the Percept RC neurostimulator. Esteemed as the first and only deep brain stimulation system with sensing, directionality, and advanced pro...

Medtronic Plc

Medtronic Plc Shocks Market with Unprecedented Growth: Unveiling Powerful Figures Across August to October 27, 2023

Medtronic Plc Shows Strong Financial Performance and Market Potential
Medtronic Plc, a leading medical technology company, has recently announced its financial results for the period ending October 27, 2023. The company demonstrated impressive growth, with significant increases in income per share, revenue, and net income.
One of the standout achievements for Medtronic Plc is the growth in income per share. Compared to the previous year, the company saw a remarkable 112.5% increase in income per share, from $0.32 to $0.68. Additionally, income per share advanced by 15.25% from the preceding reporting period, reaching $0.59 per share. This marked improvement reflects the company's ability to generate strong profits and create value for its shareholders.

Medtronic Plc

Medtronic Plc Surprises Investors with Impressive 4.491% Revenue Surge in May to July 28, 2023 Period

Investors in the stock market have been closely following the recent financial performance of Medtronic Plc, and there are some interesting developments to consider. Despite a decline in earnings per share (EPS), the company has managed to increase its revenue. In the span from May to July 28, 2023, Medtronic reported a revenue increase of 4.491% to an impressive $7.70 billion, compared to $7.37 billion in the same period the previous year.
However, there was a decrease in income of -15.71% with an EPS of $0.59, compared to $0.70 in the same period the year before. This decline in income per share can be seen as a potential concern, but it is important to remember that Medtronic Plc had previously achieved a bottom line of $0.89 per share in the preceding financial reporting period.






 

Medtronic Plc's Segments
 
Cardiac Rhythm Management
 Segment     of total Revenue
DIABETES
 Segment     of total Revenue
Spinal & ENT
 Segment     of total Revenue
CARDIOVASCULAR
 Segment     of total Revenue
NEUROMODULATION
 Segment     of total Revenue
SURGICAL TECHNOLOGIES
 Segment     of total Revenue
Cardiac Vascular
 Segment     of total Revenue
Restorative Therapies
 Segment     of total Revenue
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Medtronic Plc announced annual revenue outlook on

Earnings Outlook
Medtronic Plc issued annual earnings guidance on

 
Geographic Revenue Dispersion
United States
Europe
Asia Pacific
Other




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com